Form 8-K - Current report:
SEC Accession No. 0001104659-24-039703
Filing Date
2024-03-27
Accepted
2024-03-27 16:05:32
Documents
15
Period of Report
2024-03-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249964d1_8k.htm   iXBRL 8-K 25350
2 EXHIBIT 99.1 tm249964d1_ex99-1.htm EX-99.1 15451
6 GRAPHIC tm249964d1_ex99-1img001.jpg GRAPHIC 3200
  Complete submission text file 0001104659-24-039703.txt   226207

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrns-20240327.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20240327_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20240327_pre.xml EX-101.PRE 22369
18 EXTRACTED XBRL INSTANCE DOCUMENT tm249964d1_8k_htm.xml XML 3749
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 24790589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)